<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02599740</url>
  </required_header>
  <id_info>
    <org_study_id>FDS-NAA-2093</org_study_id>
    <nct_id>NCT02599740</nct_id>
  </id_info>
  <brief_title>Natural Fruit Extract Versus the Assumed Key Active Compound in Reducing the Post-prandial Blood Glucose Level</brief_title>
  <official_title>The Bioequivalence of a Natural Extract Versus the Assumed Key Active Compound in Reducing the Post-prandial Blood Glucose Levels</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Unilever R&amp;D</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Unilever R&amp;D</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to test bioequivalence of a assumed key active compound vs. natural
      fruit extract as judged from the Incremental area under the curve (+iAUC0-2h) for blood
      glucose: i.e. the 90% confidence interval of the ratio +iAUC0-2h for blood glucose for
      assumed key active compound vs. natural extract falls between 0.8 - 1.25.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The basic study design for this Williams design consists of six distinct treatment sequences;
      within each of the treatment sequences the treatments are duplicated.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of 2-h Post Prandial Blood Glucose (PPG) based on response to different treatments</measure>
    <time_frame>0-2 hours</time_frame>
    <description>+iAUC</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of 3-h PPG based on response to different treatments</measure>
    <time_frame>0-3 hours</time_frame>
    <description>+iAUC</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of 2-h and 3-h post-prandial insulin based on response to different treatments</measure>
    <time_frame>0-2 hours and 0-3 hours</time_frame>
    <description>tAUC</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Max plasma concentration for assumed key active</measure>
    <time_frame>0-12 hours</time_frame>
    <description>Cmax</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time of max plasma concentration for assumed key active</measure>
    <time_frame>0-12 hours</time_frame>
    <description>Tmax</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AUC for plasma concentration versus time curve for assumed key active</measure>
    <time_frame>0-12 hours</time_frame>
    <description>AUC</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Half-life of elimination phase for assumed key active</measure>
    <time_frame>0-12 hours</time_frame>
    <description>t1/2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total amount of assumed key active excreted in urine</measure>
    <time_frame>0-36 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">84</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Rice only</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Assumed active</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Assumed key active consumed with rice</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Natural fruit extract</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Natural fruit extract consumed with rice</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Natural fruit extract</intervention_name>
    <description>Natural fruit extract consumed with rice</description>
    <arm_group_label>Natural fruit extract</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Assumed active</intervention_name>
    <description>Assumed key active consumed with rice</description>
    <arm_group_label>Assumed active</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Rice only</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Body mass index (BMI) ≥ 18.5 and ≤ 25.0 kg/m2.

          -  Apparently healthy males and females: no medical conditions which might affect the
             study measurements, absorption, metabolism and distribution (including diabetes type 1
             and type 2, gastrointestinal dysfunction, gastrointestinal surgery [with exception of
             cholecystectomy and appendectomy] and inflammatory diseases).

          -  Fasting blood glucose value of subjects is ≥ 3.4 and &lt;6.1 mmol/litre (i.e. 62- 110
             mg/dl) at screening.

        Exclusion Criteria:

          -  Use of antibiotics within 3 months before day 1; use of any other medication within 14
             days before day 1 except for both paracetamol and hormonal contraception.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian Keicher, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charité Research Organisation GmbH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Charité Research Organisation GmbH</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 3, 2015</study_first_submitted>
  <study_first_submitted_qc>November 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 9, 2015</study_first_posted>
  <last_update_submitted>January 14, 2016</last_update_submitted>
  <last_update_submitted_qc>January 14, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Blood glucose</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

